Skip to content

Effects of Nordic Walking on Prenatal Health

Effects of Nordic Walking on Prenatal Health: A Focus on Gait Kinematics, Musculoskeletal Pain, and Quality of Life. A Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06673147
Acronym
Nordic Walking
Enrollment
55
Registered
2024-11-04
Start date
2024-11-05
Completion date
2025-06-29
Last updated
2025-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prenatal Care, Walking

Keywords

Prenatal health Nordic walking, pregnancy, musculoskeletal pain, gait parameters, quality of life

Brief summary

This randomized controlled trial (RCT) aimed to evaluate the effects of Nordic walking (NW) on gait kinematics, musculoskeletal pain, and quality of life in pregnant women.

Detailed description

Healthy pregnant women (N=50), aged 20-40 years and between 13 and 28 weeks of gestation, experiencing mild to moderate musculoskeletal pain, will be recruited. Participants will be randomized into either an intervention group (NW training) or a control group receiving standard prenatal care. The intervention group will undergo a 4-week learning phase followed by an 8-week NW program (3 sessions per week, 45 minutes per session), led by a certified instructor. Outcome measures will be assessed at baseline, after 4 weeks, and post-intervention (8 weeks), including spatiotemporal gait parameters (will be assessed using the GAITRite system), musculoskeletal pain (will be measured via Visual Analog Scale, VAS), and quality of life (will be measured using the SF-36 Health Survey).

Interventions

OTHERPrenatal Nordic Walking

Traditional Nordic walking poles will be modified according to International Nordic Walking Federation guidelines, which meant that the elbows were bent at a 90°angle when holding the poles in a vertical position. Nordic Walking will be conducted in two phases consisting of a 4-week learning phase followed by an 8-week main phase of intervention.

Sponsors

University of Jazan
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Out of 50 pregnant women who will be screened for their eligibility criteria, The participants will be randomized to either intervention group (Nordic Walking) or control group (standard prenatal care).

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy women aged 20 to 40 between 13 and 28 weeks into singleton pregnancy. * Participants must be experiencing mild to moderate musculoskeletal discomfort, such as lower back or pelvic pain, * Participants have no prior musculoskeletal or neurological diseases. * They must have no contraindications to exercising throughout pregnancy, as established by obstetrician clearance, and be able to engage in moderate physical activity under medical recommendations

Exclusion criteria

* History of diseases affecting bony structures or lumbar intervertebral discs. * Pain caused by non-musculoskeletal factors (such as urinary tract infections or obstetric complications). * Multiple pregnancies, pre-existing mobility conditions, and high-risk pregnancies or complications that restrict physical activity.

Design outcomes

Primary

MeasureTime frameDescription
Spatial gait parameters20 minutesA GAITRite system will be used to assess the spatial parameters of gait
Temporal parameters of gait20 minutesA GAITRite system will be used to assess the temporal parameters of gait

Secondary

MeasureTime frameDescription
Visual Analog Score for musculoskeletal pain5 minutesThe Visual Analog Score is depicted as a 10 cm horizontal line divided into 1 cm sections, each representing 1 point, resulting in a score ranging from 0 to 10 points. Higher scores mean worse outcome.
Quality of life10 minutesThe SF-36 Health Survey will be used to determine the results.

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026